ShareValue scores for 605199.SHG: Valuation 46, Quality 32, Growth 25, Health 33.
605199.SHGSSE
Hainan Huluwa Pharmaceutical Group Co Ltd
CN¥6.03
(+0.33%)
605199.SHGSSE
Hainan Huluwa Pharmaceutical Group Co Ltd
CN¥6.03(+0.33%)
Loading chart...
Sentiment
Verdicts
Value:Fair Value
Quality:Weak
Growth:Weak
Health:Stressed
Verdicts
Fundamental Rating
Value Trap Risk
Expected Return
1% to 15%
Rating
Trap Risk
Return
1% to 15%
Valuation
46
Fair Value
Price vs Value
Quality
32
Weak
Business Strength
Growth
25
Weak
Revenue & Earnings
Health
33
Stressed
Financial Stability
Momentum
22
Bearish
Price Trend
Company Details
About
Hainan Huluwa Pharmaceutical Group Co., Ltd. research, develops, produces, and sells drugs in the areas of Children's digestive system, respiratory system, anti-infection, anti-virus and other fields in China. The company offers pediatrics, gynecology, antibiotics, respiratory, digestive system, cardiovascular and cerebrovascular, nourishment, and other medicine products. Hainan Huluwa Pharmaceutical Group Co., Ltd. was founded in 2005 and is based in Haikou, China.
Market Cap$2.41B
P/E RatioN/A
Dividend YieldNone
Sector Rank#2762
Score Analysis
AI Investment Thesis
Data as of:Aug 7, 2026
|Last calculated:Aug 7, 2026